We are live on ! Find out more
BGMSP

Bio Green Med Solution Inc Preferred Stock

Delisted

BGMSP was delisted on the 20th of March, 2026.

2 hedge funds and large institutions have $1.3K invested in Bio Green Med Solution Inc Preferred Stock in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

110% more capital invested

Capital invested by funds: $619 → $1.3K (+$678)

100% more funds holding

Funds holding: 12 (+1)

0.02% more ownership

Funds ownership: 0.03%0.05% (+0.02%)

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$565

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
SIS
1
Sound Income Strategies
Florida
$685
UBS Group
2
UBS Group
Switzerland
$612 +$565 +84 New

BGMSP Hedge Fund Activity: Q4 2024 in Review

2 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution Inc Preferred Stock (BGMSP) for Q4 2024, worth a combined $1.3K — up 110% from $619 a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new BGMSP positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $565.

  • 2 institutional investors held Bio Green Med Solution Inc Preferred Stock (BGMSP) as of Q4 2024, up from 1 in Q3 2024.
  • Funds reported $1.3K of Bio Green Med Solution Inc Preferred Stock stock for Q4 2024, up 110% quarter-over-quarter.
  • 1 fund opened new Bio Green Med Solution Inc Preferred Stock positions in Q4 2024 and 0 closed out, a net change of +1 holder.
  • The largest Bio Green Med Solution Inc Preferred Stock buyer in Q4 2024 was UBS Group, an estimated $565 added.

Based on aggregated 13F filings for Q4 2024.